Grifols, S.A.
$8.19+4.46%(+$0.35)
TickerSpark Score
71/100
90
Valuation
75
Profitability
70
Growth
72
Health
50
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRFS research report →
52-Week Range21% of range
Low $7.39
Current $8.19
High $11.14
Companywww.grifols.com
Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives.
- CEO
- Jose Ignacio Abia Buenache
- IPO
- 2011
- Employees
- 23,833
- HQ
- Barcelona, ES
Price Chart
+1.87% · this period
Valuation
- Market Cap
- $6.93B
- P/E
- 15.68
- P/S
- 0.88
- P/B
- 1.19
- EV/EBITDA
- 10.80
- Div Yield
- 1.57%
Profitability
- Gross Margin
- 37.68%
- Op Margin
- 16.89%
- Net Margin
- 5.58%
- ROE
- 7.88%
- ROIC
- 5.49%
Growth & Income
- Revenue
- $7.23B · 0.20%
- Net Income
- $386.13M · 146.07%
- EPS
- $0.57 · 147.83%
- Op Income
- $1.19B
- FCF YoY
- 41.51%
Performance & Tape
- 52W High
- $11.14
- 52W Low
- $7.39
- 50D MA
- $8.05
- 200D MA
- $9.05
- Beta
- 1.17
- Avg Volume
- 766.96K
Get TickerSpark's AI analysis on GRFS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GRFS Coverage
We haven't published any research on GRFS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GRFS Report →